{"article_title": "The Coming Government Takeover of Drug Pricing", "article_keywords": ["restrictions", "task", "street", "wall", "washington", "drug", "takeover", "pricing", "coming", "white", "republican", "similar", "theres", "unlikely"], "article_url": "http://www.wsj.com/articles/the-coming-government-takeover-of-drug-pricing-1448231481", "article_text": "Hillary Clinton has plenty of allies as she demonizes drug-company profits and pushes for federal control over how drugs are priced. There\u2019s a drug-pricing task force led by the White House and a similar Democrat-led effort in Congress.\n\nMany of the pharma industry\u2019s proponents in Washington and on Wall Street dismiss this as political noise, arguing that new restrictions impeding investment and innovation are unlikely to get through a Republican Congress. But the Affordable Care Act reordered the legal framework to let a...", "article_metadata": {"article.template": "snippet", "article.created": "2015-11-22T22:31:00.000Z", "article.section": "Opinion", "page.region": "na,us", "page.content.type": "Article", "twitter": {"domain": "wsj.com", "description": "In The Wall Street Journal, Scott Gottlieb writes about the coming government takeover of drug pricing\u2014ObamaCare provides the tools for a unilateral move against the industry the left loves to demonize.", "title": "The Coming Government Takeover of Drug Pricing", "image": {"src": "https://si.wsj.net/public/resources/images/ED-AU396_SGOTTL_G_20151122134645.jpg", "alt": "The Coming Government Takeover of Drug Pricing", "identifier": "https://si.wsj.net/public/resources/images/ED-AU396_SGOTTL_D_20151122134645.jpg"}, "site": "@WSJ", "card": "summary_large_image"}, "al": {"ios": {"url": "wsj://launch?articleid=SB10035478506862654305004581351451265406810&headline=The%20Coming%20Government%20Takeover%20of%20Drug%20Pricing&weburl=http://www.wsj.com/articles/SB10035478506862654305004581351451265406810"}}, "page.site.product": "WSJ", "keywords": "Independent Payment Advisory Board,research,development,corporate,industrial news,political,general news,politics,international relations,domestic politics,commentaries,opinions,pharmaceuticals,health care,life sciences", "news_keywords": "Independent Payment Advisory Board,research,development,corporate,industrial news,political,general news,politics,international relations,domestic politics", "article.headline": "The Coming Government Takeover of Drug Pricing", "cXenseParse": {"candybar": {"image": "https://si.wsj.net/public/resources/images/ED-AU396_SGOTTL_E_20151122134645.jpg"}, "poptart": {"image": "https://si.wsj.net/public/resources/images/ED-AU396_SGOTTL_D_20151122134645.jpg"}}, "description": "In The Wall Street Journal, Scott Gottlieb writes about the coming government takeover of drug pricing\u2014ObamaCare provides the tools for a unilateral move against the industry the left loves to demonize.", "apple-itunes-app": "app-id=364387007,app-argument=wsj://launch?articleid=SB10035478506862654305004581351451265406810&headline=The%20Coming%20Government%20Takeover%20of%20Drug%20Pricing&weburl=http://www.wsj.com/articles/SB10035478506862654305004581351451265406810", "user.type": "nonsubscriber", "testkeys": "A", "article.page": "Commentary", "article.summary": "In The Wall Street Journal, Scott Gottlieb writes about the coming government takeover of drug pricing\u2014ObamaCare provides the tools for a unilateral move against the industry the left loves to demonize.", "page.site": "wsj", "page.content.format": "responsive", "article.published": "2015-11-22T22:31:00.000Z", "dj.asn": "i-4bd2", "robots": "noarchive,noodp", "fb": {"app_id": 368513495882}, "article": {"publisher": "https://www.facebook.com/wsj", "image_count": 1, "word_count": 807, "external_link_count": 2}, "viewport": "width=device-width, initial-scale=1.0, minimum-scale=1.0, maximum-scale=1.0, user-scalable=no", "page.section": "Article", "language": "en-US", "og": {"site_name": "WSJ", "description": "In The Wall Street Journal, Scott Gottlieb writes about the coming government takeover of drug pricing\u2014ObamaCare provides the tools for a unilateral move against the industry the left loves to demonize.", "title": "The Coming Government Takeover of Drug Pricing", "url": "http://www.wsj.com/articles/the-coming-government-takeover-of-drug-pricing-1448231481", "image": {"width": 553, "identifier": "https://si.wsj.net/public/resources/images/ED-AU396_SGOTTL_G_20151122134645.jpg", "height": 369}, "locale": "en_US", "type": "article"}, "author": "Scott Gottlieb", "article.access": "paid", "page.content.source": "WSJ Online Article", "article.origheadline": "The Coming Government Takeover of Drug Pricing", "article.type": "Commentary (U.S.)", "article.id": "SB10035478506862654305004581351451265406810", "user.exp": "default", "article.updated": "2015-11-22T22:31:00.000Z"}, "article_summary": "There\u2019s a drug-pricing task force led by the White House and a similar Democrat-led effort in Congress.\nHillary Clinton has plenty of allies as she demonizes drug-company profits and pushes for federal control over how drugs are priced.\nMany of the pharma industry\u2019s proponents in Washington and on Wall Street dismiss this as political noise, arguing that new restrictions impeding investment and innovation are unlikely to get through a Republican Congress.\nBut the Affordable Care Act reordered the legal framework to let a..."}